CSIR Central

Aryloxy cyclohexyl imidazoles: a novel class of antileishmanial agents

IR@CDRI: CSIR-Central Drug Research Institute, Lucknow

View Archive Info
 
 
Field Value
 
Creator Srinivas, Nagarapu
Palne, Shraddha
Nishi
Gupta, Suman
Bhandari, Kalpana
 
Date 2010-09-04T06:35:15Z
2010-09-04T06:35:15Z
2009
 
Identifier Bioorganic & Medicinal Chemistry Letters,19 (2)2009,324-327
http://hdl.handle.net/123456789/581
 
Description Thirteen novel aryloxy cyclohexane based mono and bis imidazoles were synthesized and evaluated in vitro as antileishmanials against L. donovani and cytotoxicity assessed. These compounds were better than the existing drugs, sodium stibogluconate and pentamidine in respect to IC50 and SI values. Promising compounds were tested further in-vivo. Among all, the bis methylimidazole with 2-fluoro, 4-nitro aryloxy group (9) exhibited significant in vivo inhibition of 77.9 %, thus providing new structural lead for antileishmanials.
 
Format 126925 bytes
application/pdf
 
Language en
 
Subject Leishmania
azoles
imidazoles
aryloxy cyclohexane
 
Title Aryloxy cyclohexyl imidazoles: a novel class of antileishmanial agents
 
Type Article